Alcohol in excess: CRF1 receptors in the rat and mouse VTA and DRN

Psychopharmacology

Volumn 225, Issue 2, 2013, Pages 313-327

  Hwa, Lara S ^a   Debold, Joseph F ^a   Miczek, Klaus A ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; CRF; Dorsal raphe; Drinking; VTA

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DOPAMINE;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRINKING BEHAVIOR; HISTOLOGY; HORMONE RECEPTOR INTERACTION; MALE; MOUSE; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SPECIES DIFFERENCE; VENTRAL TEGMENTUM;

ALCOHOL DRINKING; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; ETHANOL; MALE; MICE; MICE, INBRED C57BL; PYRIMIDINES; PYRROLES; RAPHE NUCLEI; RATS; RATS, LONG-EVANS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SPECIES SPECIFICITY; VENTRAL TEGMENTAL AREA;

EID: 84872334731     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2820-z     Document Type: Article

References (100)

1. Becker HC (1998) Kindling in alcohol withdrawal. Alcohol Health Res World 22:25-33
2. Beckstead MJ, Gantz SC, Ford CP, Stenzel-Poore MP, Phillips PEM, Mark GP, Williams JT (2009) CRF enhancement of GIRK channel-mediated transmission in dopamine neurons. Neuropsychopharmacology 34:1926-1935
3. Berman RF, Cannon DS (1974) The effect of prior ethanol experience on ethanol-induced saccharin aversions. Physiol Behav 12:1041-1044
4. Boyson CO, Miguel TT, Quadros IM, DeBold JF, Miczek KA (2011) Prevention of social stress-escalated cocaine self-administraiton by CRF-R1 antagonist in the rat VTA. Psychopharmacology 218:257-269
5. Branchey L, Shaw S, Lieber CS (1981) Ethanol impairs tryptophan transport into the brain and depresses serotonin. Life Sci 29:2751-2755
6. Brodie MS, Appel SB (2000) Dopaminergic neurons in the ventral tegmental area of C57BL/6J and DBA/2J mice differ in sensitivity to ethanol excitation. Alcohol Clin Exp Res 24:1120-1124
7. Carlsson A, Engel J, Strombom U, Svensson TH, Waldeck B (1974) Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn Schmiedebergs Arch Pharmacol 283:117-128
8. Chalmers DT, Lovenberg TW, De Souza EB (1995) Localization of novel corticotroin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350
9. Chen C (2006) Recent advances in small molecule antagonists of the corticotropin-releasing factor type-1 receptor - focus on pharmacology and pharmacokinetics. Curr Med Chem 13:1261-1282
10. Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ (2007) Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol Biochem Behav 86:813-821
11. Cippitelli A, Damadzic R, Singley E, Thorsell A, Ciccocioppo R, Eskay RL, Heilig M (2012) Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav 100: 522-529
12. Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale WW et al (2000) Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 141:2698-2702
13. D'Este L, Casini A, Puglisi-Allegra S, Cabib S, Renda TG (2007) Comparative immunohistochemical study of the dopaminergic systems in two inbred mouse strains (C57BL/6J and DBA/2J). J Chem Neuroanat 33:67-74
14. Deutch AY, Bean AJ, Bissette G, Nemeroff CB, Robbins RJ, Roth RH (1987) Stress-induced alterations in neurotensin, somatostatin and corticotropin- releasing factor in mesotelencephalic dopamine system regions. Brain Res 417:350-354
15. Deutch AY, Lee MC, Gillham MH, Cameron DA, Goldstein M, Iadarola MJ (1991) Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex 1:273-292
16. Diana M, Gessa GL, Rossetti ZL (1992) Lack of tolerance to ethanol-induced stimulation of mesolimbic dopamine system. Alcohol Alcohol 27:329-333
17. DiChiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274-5278
18. Finn DA, Snelling C, Fretwell AM, Tanchuck MA, Underwood L, Cole M et al (2007) Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist d-Phe-CRF(12-41). Alcohol Clin Exp Res 31:939-949
19. Fuller JL (1964) Measurement of alcohol preference in genetic experiments. J Comp Physiol Psychol 57:85-88
20. Funk CK, Koob GF (2007) A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res 1155:172-178
21. Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF (2007) Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 61:78-86
22. Gatto GJ, McBride WJ, Murphy JM, Lumeng L, Li TK (1994) Ethanol self-infusion into the ventral tegmental area by alcohol-preferring rats. Alcohol 11:557-564
23. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C et al (2007) 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6- dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27:2718-2726
24. Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G (1985) Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348:201-203
25. Giardino WJ, Cocking DL, Kaur S, Cunningham CL, Ryabinin AE (2011) Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference. PLoS One 6:e26997
26. Gilpin NW, Richardson HN, Koob GF (2008) Effects of CRF(1)-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res 32: 1535-1542
27. Goldstein DB, Kakihana R (1977) Circadian rhythms of ethanol consumpton in mice: a simple computer analysis for chronopharmacology. Psychopharmacology 52:41-45
28. Gonzales RA, Job MO, Doyon WM (2004) The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther 103:121-146
29. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF (1996) Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54:129-141
30. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Björk K, Soverchia L et al (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Nat Acad Sci 103:15236-15241
31. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5:453-479
32. Hauser SR, Ding ZM, Getachew B, Toalson JE, Oster SM, McBride WJ, Rodd ZA (2011) The posterior ventral tegmental area mediates alcohol-seeking behavior in alcohol-preferring rats. J Pharmacol Exp Ther 336:857-865
33. Heinrichs SC, Richard D (1999) The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 33:350-359
34. Hwa LS, Chu A, Levinson SA, Kayyali TM, DeBold JF, Miczek KA (2011a) Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20 % ethanol. Alcohol Clin Exp Res 35:1938-1947
35. Hwa LS, Kayyali T, DeBold JF, Miczek KA (2011b) Excessive alcohol drinking in C57BL/6J mice due to intermittent access to alcohol: influence of CRF and opioid systems. Research Abstract for Res Soc Alcoholism Annual Scientific Meeting. Alcohol Clin Exp Res 6(Suppl):69A
36. Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165-229
37. Kauer JA (2004) Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 66:447-475
38. Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-858
39. Kehne JH (2007) The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders. CNS Neurol Disord Drug Targets 6:163-182
40. Keifer SW, Bice PJ, Badia-Elder N (1994) Alterations in taste reactivity to alcohol in rats given continuous alcohol access followed by abstinence. Alcohol Clin Exp Res 18:555-559
41. Kirby LG, Rice KC, Valentino RJ (2000) Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22:148-162
42. Koob GF (2003) Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur Neuropsychopharmacol 13:442-452
43. Koob GF, Le Moal ML (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52-59
44. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek KA et al (1992) The role of corticotropin-releasing factor in behavioural responses to stress. CIBA Found Symp 172:277-295
45. Korotkova TM, Brown RE, Sergeeva OA, Ponomarenko AA, Haas HL (2006) Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci 23:2677-2685
46. LeMarquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 36:395-421
47. Lodge DJ, Grace AA (2005) Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity. J Pharmacol Exp Ther 314:201-206
48. Lowery EG, Thiele TE (2010) Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol Disord Drug Targets 9:77-86
49. Lowery-Gionta EG, Navarro M, Li C, Pliel KE, Rinker JA, Cox BR, Sprow GM, Kash TL, Thiele TE (2012) Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J Neurosci 32:3405-3413
50. Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F et al (1996) A non-peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 309:195-200
51. McClearn GE, Rodgers DA (1959) Differences in alcohol preference among inbred strains of mice. Q J Stud Alcohol 20:691-695
52. Melendez RI (2011) Intermittent (every-other-day) drinking induces rapid escalation of ethanol intake and preference in adolescent and adult C57BL/6J mice. Alcohol Clin Exp Res 35:652-658
53. Melon LC, Boehm SL (2011) GABAA receptors in the posterior, but not anterior, ventral tegmental area mediate Ro15-4513-induced attenuation of binge-like ethanol consumption in C57BL/6J female mice. Behav Brain Res 220:230-237
54. Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF (1994) Characterization of a novel and poten corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 269:564-572
55. Merlo-Pich PE, Lorang M, Yeganeh M, Rodriguez dF, Raber J, Koob GF et al (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15:5439-5447
56. Molliver ME (1987) Serotonergic neuronal systems: what their anatomic organization tells us about function. J Clin Psychopharmacol 7:3S-23S
57. Paxinos G, Franklin K (2003) The mouse brain in stereotaxic coordinates. Elsevier Academic, San Diego
58. Paxinos G, Watson C (1997) The rat brian in stereotaxic coordinates. Academic, San Diego
59. Pelleymounter MA, Joppa M, Carmouche M, Cullen MJ, Brown B et al (2000) Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrom induced by CRF. J Pharmacol Exp Ther 293:799-806
60. Pfeffer AO, Samson HH (1986) Effect of pimozide on home cage ethanol drinking in the rat: dependence on drinking session length. Drug Alcohol Depend 17:47-55
61. Pinel JP, Huang E (1976) Effects of periodic withdrawal on ethanol and saccharin selection in rats. Physiol Behav 16:693-698
62. Price ML, Lucki I (2001) Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 21:2833-2841
63. Price ML, Curtis AL, Kirby LJ, Valentino RJ, Lucki I (1998) Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18:492-502
64. Rassnick S, Stinus L, Koob GF (1993) The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res 623:16-24
65. Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC (2005) Evaluation of a simple model of ethanol drinking to intoxicaiton in C57BL/6J mice. Physiol Behav 84:53-63
66. Richardson HN, Zhao Y, Fekete EM, Funk CK, Wirsching P, Janda KD, Zorrilla EP, Koob GF (2008) MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol Biochem Behav 88:497-510
67. Rodd ZA, Bell RL, Melendez RI, Kuc KA, Lumeng L, Li TK et al (2004) Comparison of intracranial self-administration of ethanol within the posterior ventral tegmental area between alcohol-preferring and Wistar rats. Alcohol Clin Exp Res 28:1212-1219
68. Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221:227-234
69. Ryabinin AE, Weitemier AZ (2006) The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption. Brain Res Rev 52:368-380
70. Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, Zorrilla EP (2006) Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology 189:175-186
71. Sakanaka M, Shibasaki T, Lederis K (1986) Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382:213-238
72. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M et al (1996) CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A 93:10477-10482
73. Sharpe AL, Phillips TJ (2009) Central urocortin 3 administraiton decrases limited access ethanol intake in non-dependent mice. Behav Pharmacol 20:326-351
74. Shen RY, Chiodo LA (1993) Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area. Brain Res 622:289-293
75. Simms JA, Steensland P, Medina B, Abernathy KE, Chandler LJ, Wise R et al (2008) Intermittent access to 20 % ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol Clin Exp Res 32:1816-1823
76. Sinclair JD, Senter RJ (1968) Development of an alcohol-deprivation effect in rats. Q J Stud Alcohol 29:863-867
77. Smith SM, Vale WW (2006) The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 8:383-395
78. Spanagel R, Weiss F (1999) The dopamine hypothesis of reward: past and current studies. Trends Neurosci 22:521-527
79. Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE (2008) Blockade of corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 32:259-265
80. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, Koob GF (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273:1561-1564
81. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186
82. Tabakoff B, Ritzmann RF (1975) Inhibition of the transport of 5-hydroxyindoleacetic acid from brain by ethanol. J Neurochem 24:1043-1051
83. Tagliaferro P, Morales M (2008) Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J Comp Neurol 506:616-626
84. Thierry AM, Tassin JP, Blanc G, Glowinski J (1976) Selective activation of the mesocortical DA system by stress. Nature 263:242-243
85. Tomie A, Miller WC, Dranoff E, Pohorecky LA (2006) Intermittent presentations of ethanol sipper tube induce ethanol drinking in rats. Alcohol Alcohol 41:225-230
86. Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M et al (2006) Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11:594-602
87. Valdez GR, Koob GF (2004) Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav 79:671-689
88. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP et al (2002) Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26:1494-1501
89. Valdez GR, Sabino V, Koob GF (2004) Increased anxiety-like behavior and ethanol self-administraiton in dependent rats: reversal via corticotropin- releasing factor-2 receptor activation. Alcohol Clin Exp Res 28:865-872
90. Valentino RJ, Commons KG (2005) Peptides that fine-tune the serotonin system. Neuropeptides 39:1-8
91. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A (2008) Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol 586:2157-2170
92. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB (2005) Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 25:5389-5396
93. Wang B, You ZB, Rice KC, Wise RA (2007) Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl) 193:283-294
94. Wayner MJ, Greenberg I (1972) Effects of hypothalamic stimulation, acclimation and periodic withdrawal on ethanol consumption. Physiol Behav 9:737-740
95. Weiss F, Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom FE et al (1996) Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 16:3474-3485
96. Weitemier AZ, Ryabinin AE (2006) Urocortin 1 in the dorsal raphe regulates food and fluid consumption, but not ethanol preference in C57BL/6J mice. Neuroscience 137:1439-1445
97. Wise RA (1973) Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia 29:203-210
98. Wise RA (1996) Neurobiology of addiction. Curr Opin Neurobiol 6:243-251
99. Zorrilla EP, Koob GF (2004) The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs 13:799-828
100. Zorrilla EP, Koob GF (2010) Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov Today 15:371-383